Wilms tumor: progress and considerations for the surgeon.
Ehrlich PF.
Ehrlich PF.
Surg Oncol. 2007 Nov;16(3):157-71. doi: 10.1016/j.suronc.2007.07.001. Epub 2007 Aug 3.
Surg Oncol. 2007.
PMID: 17689073
Review.
Treatment is now progressing towards "risk-based management"- based not only on stage and histology but also incorporating genetic markers [Dome JS, Grundy PE, Perlman EJ, Ehrlich PF, et al. Protocols for the renal tumors study. Childrens Oncology Group. [www.childr …
Treatment is now progressing towards "risk-based management"- based not only on stage and histology but also incorporating genetic markers [ …